8-K 1 w69006e8vk.htm TRM CORPORATION FORM 8-K e8vk
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported) November 12, 2004

TRM CORPORATION

(Exact Name of Registrant as Specified in Its Charter)
           
Oregon   0-19657   93-0809419  
(State or Other Jurisdiction   (Commission File Number)   (IRS Employer  
of Incorporation)       Identification No.)  

5208 N.E. 122nd Avenue
Portland, Oregon 97230

(Address of Principal Executive Offices) (Zip Code)

(503) 257-8766

(Registrant’s Telephone Number, Including Area Code)

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 


 

Item 5.02 Departure of Directors or Principal Officers; Election of Directors;
Appointment of Principal Officers

     On November 15, 2004, Jon S. Pitcher was appointed the Company’s Principal Accounting Officer, replacing Rebecca J. Demy, who resigned on November 12, 2004. Mr. Pitcher, age 55, previously served as Corporate Controller and Director of Revenue since joining the Company in December 2003. Mr. Pitcher was self-employed from April 2001 until December 2003, providing accounting and consulting services to private and publicly-held clients. From 1991 though March 2001, Mr. Pitcher was Chief Financial Officer of OXIS International, Inc., a publicly-traded pharmaceutical development company.

2


 

Signatures

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
         
  TRM Corporation
Registrant
 
 
Date: November 18, 2004  By:   /s/ Daniel E. O’Brien    
    Daniel E. O’Brien   
    Chief Financial Officer